Clinical Trial Update: Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCT [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating topical cyclosporine to prevent ocular graft-versus-host disease in recipients of allogeneic hematopoietic stem cell transplantation …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• cyclosporine (topical) (cyclosporine)

Snippet

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez | Conditions: Graft-Versus-Host Disease | Phase 2 | Status: COMPLETED